Trials / Completed
CompletedNCT06064799
GCF miRNA-223 , -214 Levels in Smokers and Nonsmokers Periodontitis Patients
Expression of microRNA-223 and microRNA-214 in Gingival Crevicular Fluid of Smoker and Nonsmoker Periodontitis Patients, an Observational Diagnostic Accuracy Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 42 (actual)
- Sponsor
- Fayoum University · Academic / Other
- Sex
- All
- Age
- 20 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
Objective: Periodontitis is a multifactorial disease that affects a wide range of populations. However, its pathogenesis remains unclear. miRNAs are now considered potential diagnostic markers for many inflammatory diseases. Thus, the aim of this study was to assess the expression of microRNA-223(miRNA-223) and microRNA-214 (miRNA-214) in gingival crevicular fluid (GCF) of smoker and nonsmoker with periodontitis. Materials and Methods: We conducted a prospective study among 42 participants: 14 healthy controls, 14 nonsmoker periodontitis participants, and 14 smoker with periodontitis. Eligibility criteria for inclusion were consecutive adults, aged 20-60 years, with stage III periodontitis grade B/C and no systemic diseases. All consenting participants had gingival crevicular fluid samples collected after diagnosis to assess miRNA-214 and -223 by quantitative real-time polymerase chain reaction assay.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | miRNA-223 & -214 detection | miRNA-223 \& -214 detection in GCF samples by PCR kits |
Timeline
- Start date
- 2023-01-01
- Primary completion
- 2023-06-30
- Completion
- 2023-06-30
- First posted
- 2023-10-03
- Last updated
- 2023-10-03
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT06064799. Inclusion in this directory is not an endorsement.